A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression

Abroad (travel likely)Recruiting

Conditions

Treatment Resistant Depression

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • University of Alabama at Birmingham, Birmingham, Alabama, United States

    Contact: Study coordinator (Candace Green) · candacegreen@uabmc.edu · 205-976-0068
    Contact: Principal Investigator (Matthew Macaluso, DO)
  • UAB Huntsville Regional Medical Center, Huntsville, Alabama, United States

    Contact: Study coordinator (Michael Howell) · hsvpsychresearch@uabmc.edu · 256-551-4431
    Contact: Principal Investigator (Richard Shelton)
  • Access Multi Specialty Medical Clinic, Inc, Burlingame, California, United States

  • CMB Clinical Trials, Colton, California, United States

  • ATP Clinical Research, Inc., Costa Mesa, California, United States

    Contact: Study coordinator (Bobby Shih) · bshih@atpcr.com · 714-277-4472
    Contact: Principal Investigator (Gustavo Alva, MD)
  • Kaizen Brain Center, La Jolla, California, United States

    Contact: Study coordinator (Melissa Escamirosa) · melissa@kaizenbraincenter.com · 866-277-2659
    Contact: Principal Investigator (Mohammed Ahmed, MD)
  • Keck Hospital of USC, Los Angeles, California, United States

    Contact: Study coordinator (Zoe Durkin) · zoe.durkin@med.usc.edu · 213-631-8487
    Contact: Principal Investigator (Ashraf Elmashat, MD)
  • University of California San Diego, San Diego, California, United States

  • SF-CARE, Inc., San Rafael, California, United States

  • Syrentis Clinical Research, Santa Ana, California, United States

  • Sunrise Research Institute, Boca Raton, Florida, United States

  • Mindful Behavioral Health, Boca Raton, Florida, United States

    Contact: Study coordinator (Alexis Archer) · alexismarie@kindresearchgroup.com · 561-499-6933
    Contact: Principal Investigator (Ivan Cichowicz, MD)
  • Medycal Research, Inc, Brooksville, Florida, United States

  • Galiz Research LLC, Hialeah, Florida, United States

    Contact: Study coordinator (Yohana Lima) · yohana@galizresearch.com · 305-805-0921
    Contact: Principal Investigator (Jose Gamez, MD)
  • Flourish Research - St. Augustine, Jacksonville, Florida, United States

    Contact: Study coordinator (Comelia Partin, RN) · cpartin@flourishresearch.com · 904-209-0043
    Contact: Principal Investigator (Heather Luing)
  • Florida Behavioral Psych, Largo, Florida, United States

    Contact: Study coordinator (Carlos Bussey) · cbussey@vantagetrials.com · 727-510-9773
    Contact: Principal Investigator (Ashok Patel, MD)
  • Segal Trials Corporate, Lauderhill, Florida, United States

  • Central Miami Medical Institute, LLC, Miami, Florida, United States

  • Clintex Research Group, Inc., Miami, Florida, United States

  • Research Center Of Florida, Inc, Miami, Florida, United States

  • Ocean Blue Medical Research Center, Miami Springs, Florida, United States

  • APG Research, LLC, Orlando, Florida, United States

    Contact: Study coordinator (Kailee Kenworthy) · kkenworthyapg@gmail.com · 407-808-1875
    Contact: Principal Investigator (Morteza Nadjafi, MD)
  • Nova Psychiatry Inc., Orlando, Florida, United States

    Contact: Study coordinator (Carmen Torres) · novapsychiatryinc@gmail.com · 401-883-9303
    Contact: Principal Investigator (David Medina, MD)
  • Florida Center for TMS, Orlando, Florida, United States

  • Millenia Psychiatry & Research, Inc, Orlando, Florida, United States

  • Quantum Laboratories Inc., Pompano Beach, Florida, United States

  • dTMS Center, LCC, Royal Palm Beach, Florida, United States

  • Florida Center for TMS, Saint Augustine, Florida, United States

  • IPTB Clinical Research, Tampa, Florida, United States

    Contact: Study coordinator (Jamie Winderbaum Fernandez) · 813-251-1800
    Contact: Principal Investigator (Jamie Winderbaum Fernandez)
  • Stedman Clinical Trials, Tampa, Florida, United States

  • K2 Medical Research, Tampa, Florida, United States

    Contact: Study coordinator (Kaitlyn Turner) · Kaitlyn.Turner@k2med.com · 813-800-5252
    Contact: Principal Investigator (Kelley Wilson, MD)
  • Psychiatric Specialty Center, West Palm Beach, Florida, United States

  • Emory University, Atlanta, Georgia, United States

    Contact: Study coordinator (Sinéad Quinn) · scquinn@emory.edu · 404-727-9228
    Contact: Principal Investigator (Patricio Riva Posse, MD)
  • Medical College of Georgia, Augusta University, Augusta, Georgia, United States

    Contact: Study coordinator (Laryssa McCloud) · lmccloud@augusta.edu · 706-721-7968
    Contact: Principal Investigator (Boadie Dunlop, MD)
  • PACT Atlanta LLC, Decatur, Georgia, United States

  • IACT Health, Grayson, Georgia, United States

  • Psych Atlanta, Marietta, Georgia, United States

    Contact: Study coordinator (Jennifer Kane) · jenniferk@nbmedicine.com · 770-422-2846
    Contact: Principal Investigator (Michael Banov, MD)
  • Pearl Health Clinic, Ammon, Idaho, United States

  • Rush University Medical Center, Chicago, Illinois, United States

    Contact: Study coordinator (Linda Skaggs) · linda_skaggs@rush.edu · 312-942-6597
    Contact: Principal Investigator (John Zajecka)
  • Joliet Center For Clinical Research, Joliet, Illinois, United States

  • AMR- Baber Research, Inc., Naperville, Illinois, United States

    Contact: Study coordinator (Freeda Baber) · freeda@baberresearchgroup.com · 630-272-4844
    Contact: Principal Investigator (Riaz Baber, MD)
  • Psychiatric Medicine Associates, LLC, Skokie, Illinois, United States

    Contact: Study coordinator (Amanda White) · awhite.pma@gmail.com · 847-679-8000
    Contact: Principal Investigator (John Zajecka, MD)
  • Southern Illinois University School of Medicine, Springfield, Illinois, United States

    Contact: Study coordinator (Oladele Owasoyo, PhD) · Oowasoyo94@siumed.edu · 217-545-7321
    Contact: Principal Investigator (Kalyan Kandra, MD)
  • Neuroscience Research Institute, Winfield, Illinois, United States

  • Advanced Research Institute, Inc., Indianapolis, Indiana, United States

  • Beacon Medical Group Behavioral Health, South Bend, Indiana, United States

  • University Of Kansas Cancer Center, Kansas City, Kansas, United States

    Contact: Study coordinator (Jasli Bonilla) · jbonilla@kumc.edu · 913-945-9790
    Contact: Principal Investigator (Tyler Kjorvestad, MD)
  • Sheppard Pratt Health System, Inc., Baltimore, Maryland, United States

    Contact: Study coordinator (Bryce Lund) · Bryce.lund1@sheppardpratt.org · 410-938-3126
    Contact: Principal Investigator (Scott Aaronson, MD)
  • Clinical Insights, Glen Burnie, Maryland, United States

  • Massachusetts General Hospital, Boston, Massachusetts, United States

    Contact: Study coordinator (Catherine Schuessler) · cschuessler@mgh.harvard.edu · 617-643-7690
    Contact: Principal Investigator (Cristina Cusin, MD)
  • Michigan Clinical Research Institute PC, Ann Arbor, Michigan, United States

    Contact: Study coordinator (Mohammad Al-Matarneh) · matarneh@earlytreatment.org · 734-834-8954
    Contact: Principal Investigator (Ravi Kirbat)
  • University of Minnesota, Minneapolis, Minnesota, United States

    Contact: Study coordinator (Kayla Thoen) · ipl@umn.edu · 952-525-4505
    Contact: Study coordinator (Rachel Johnson) · ipl@umn.edu · 952-525-4505
    Contact: Principal Investigator (Ziad Nahas, MD)
  • Precise Research Centers, Flowood, Mississippi, United States

    Contact: Study coordinator (Katherine Fickert) · kfickert@precise-research.com · 601-420-5810
    Contact: Principal Investigator (Joseph Kwentus, MD)
  • Andrew Bishop, MD, Jackson, Mississippi, United States

  • University of Missouri, Columbia, Missouri, United States

    Contact: Study coordinator (Christopher Sinkler) · sinklercs@health.missouri.edu · 573-882-5688
    Contact: Principal Investigator (Muaid Ithman, MD)
  • Psychiatric Care and Research, O'Fallon, Missouri, United States

    Contact: Study coordinator (Mary Beth Haug) · mhaug@pcrc-stl.com · 636-244-3593
    Contact: Principal Investigator (John Canale, MD)
  • Washington University School of Medicine, St Louis, Missouri, United States

    Contact: Study coordinator (Amanda Brouk) · abrouk@wustl.edu · 314-362-5113
    Contact: Principal Investigator (Donald Bohnenkamp, MD)
  • PsychCare Consultants Research, St Louis, Missouri, United States

  • Alivation Research, LLC, Lincoln, Nebraska, United States

    Contact: Study coordinator (Lisa Ludwig) · lludwig@alivation.com · 402-817-2236
    Contact: Principal Investigator (Walter Duffy, MD)
  • Healthy Perspective, Nashua, New Hampshire, United States

    Contact: Study coordinator (Nancy Gilbert, APRN) · ngilbert@hp-imhs.com · 603-880-9880
    Contact: Principal Investigator (Hisham Hafez, MD)
  • Jersey Shore University Medical Center, Neptune City, New Jersey, United States

  • University of New Mexico - Psychiatric Center, Albuquerque, New Mexico, United States

  • Dent Neurological Institute, Amherst, New York, United States

    Contact: Study coordinator (Michelle Rainka, PharmD) · mrainka@dentinstitute.com · 716-250-2038
    Contact: Principal Investigator (Horacio Capote, MD)
  • Erie County Medical Center/State University of New York (SUNY) at Buffalo Affiliate, Buffalo, New York, United States

  • Trinity Medical, Lewiston, New York, United States

    Contact: Study coordinator (Tatiana Jimenez-Knight) · tjimenezknight@chsbuffalo.org · 716-862-2426
    Contact: Principal Investigator (Alfred Belen, MD)
  • Hapworth Research Inc., New York, New York, United States

  • Icahn School of Medicine at Mount Sinai, New York, New York, United States

    Contact: Study coordinator (Esha Talati, BS) · esha.talati@mssm.edu · 332-243-7053
    Contact: Principal Investigator (James M Murrough, MD)
  • Richmond Behavioral Associates, Staten Island, New York, United States

  • Stony Brook University Hospital, Stony Brook, New York, United States

  • State University Of New York Upstate Medical University, Syracuse, New York, United States

  • ManuMind Interventional Psychiatry, Woodbury, New York, United States

    Contact: Study coordinator (Lisa Cottone) · lisa.cottone@manumind.com · 516-808-0888
    Contact: Principal Investigator (Lucian Manu, MD)
  • The Center for Neuropsychiatry and Brain Stimulation (CNBS) ARC Health, Cary, North Carolina, United States

  • Mindpath Care Centers, Raleigh, North Carolina, United States

  • Wake Forest University Health Science, Winston-Salem, North Carolina, United States

  • University Hospitals Case Medical Center, Cleveland, Ohio, United States

  • The Ohio State University, Columbus, Ohio, United States

    Contact: Study coordinator (Anne-Marie Duchemin) · anne-marie.duchemin@osumc.edu · 614-293-5517
    Contact: Principal Investigator (Kevin Reeves, MD)
  • Signature Research Associates, Inc., Fairlawn, Ohio, United States

  • Charak Center for Health and Wellness, Garfield Heights, Ohio, United States

    Contact: Study coordinator (Brooke Bhattacharya, MS) · bbhattacharya@charakcenter.com · 715-209-4321
    Contact: Principal Investigator (Rakesh Ranjan, MD)
  • NPC Research, Oklahoma City, Oklahoma, United States

  • Rivus Wellness & Research Institute, Oklahoma City, Oklahoma, United States

  • University of Oklahoma School of Community Medicine, Tulsa, Oklahoma, United States

    Contact: Study coordinator (Michelle Matukewicz, MHR) · Michelle-matukewicz@ouhsc.edu · 918-660-3118
    Contact: Principal Investigator (Ondria Gleason, MD)
  • Scranton Medical Institutes, Moosic, Pennsylvania, United States

    Contact: Study coordinator (Stephanie Terranella) · sterranella@gminstitutes.com · 570-346-3686
    Contact: Study coordinator (Zoha Babar) · zbabar@gminstitutes.com · 570-346-3686
    Contact: Principal Investigator (Matthew Berger, MD)
  • University of Pennsylvania, Philadelphia, Pennsylvania, United States

    Contact: Study coordinator (Joanna Zheng) · Joanna.Zheng@Pennmedicine.upenn.edu · 215-746-3513
    Contact: Principal Investigator (Yvette Sheline, MD)
  • Medical University of South Carolina, Charleston, South Carolina, United States

    Contact: Study coordinator (Morgan Dancy) · maddoxm@musc.edu · 843-876-5141
    Contact: Principal Investigator (Mark George, MD)
  • Neuroscience and TMS Treatment Center, Brentwood, Tennessee, United States

    Contact: Study coordinator (Anna Raines Guidry) · anna.guidry@hopeforyourbrain.com · 615-973-9243
    Contact: Principal Investigator (Jonathan Becker, MD)
  • UT Health Austin, Mulva Clinic for the Neurosciences, Austin, Texas, United States

    Contact: Study coordinator (Tyler Wilson) · tyler.wilson@austin.utexas.edu · 512-495-5566
    Contact: Study coordinator (Tara Upchurch) · tara.upchurch@austin.utexas.edu · 512-495-5566
    Contact: Principal Investigator (Julie Farrington, MD)
  • BioBehavioral Research of Austin, Austin, Texas, United States

  • University of Texas Southwestern, Dallas, Texas, United States

    Contact: Study coordinator (Hila Abush Segev, PhD) · Hila.abushsegev@utsouthwestern.edu · 214-648-0401
    Contact: Principal Investigator (Kala Bailey, MD)
  • Texas Tech University Health Science Center, El Paso, Texas, United States

    Contact: Study coordinator (Peter Thompson (PI), MD) · pm.thompson@ttuhsc.edu · 915-215-5850
  • The University Of Texas Medical School At Houston - UT Center Of Excellence On Mood Disorders, Houston, Texas, United States

    Contact: Study coordinator (Marcela Carbajal Tamez) · cip.research@uth.tmc.edu · 713-486-2567
    Contact: Principal Investigator (Joao De Quevedo, MD, PhD)
  • Houston Clinical Trials, Houston, Texas, United States

  • Northpointe Psychiatry, Lewisville, Texas, United States

    Contact: Study coordinator (Asad Islam (PI), MD) · northpointe.research@gmail.com · 214-799-8277
  • Rise Clinical Research, LLC, Missouri City, Texas, United States

  • The University of Utah, Salt Lake City, Utah, United States

    Contact: Study coordinator (Brian Mickey (PI), MD, PhD) · 801-587-3297
    Contact: Study coordinator (Sarah Kwon) · sarah.kwon@hsc.utah.edu · (801) 829-7382
  • Neuropsychiatric Associates, Plc, Woodstock, Vermont, United States

  • Carilion Clinic, Roanoke, Virginia, United States

    Contact: Study coordinator (Maryann Hollen) · mhollen@carilionclinic.org · 540-527-4875
    Contact: Principal Investigator (Anita Kablinger, MD)
  • Center For Anxiety and Depression, Mercer Island, Washington, United States

    Contact: Study coordinator (David L Dunner (PI), MD) · dldunner@comcast.net · 206-230-0330
  • Seattle Neuropsychiatric Treatment Center, Seattle, Washington, United States

    Contact: Study coordinator (Allison Chen) · recovervns@seattlentc.com · 206-467-6300
    Contact: Principal Investigator (Rebecca Allen, MD)
  • Marshall University Joan C. Edwards School of Medicine, Huntington, West Virginia, United States

    Contact: Study coordinator (Dakota May, MD) · May110@marshall.edu · 304-691-1500
    Contact: Principal Investigator (Dakota May, MD)
  • West Virginia Clinical and Translational Science Institute, Morgantown, West Virginia, United States

  • University of Wisconsin, Madison, Wisconsin, United States

    Contact: Study coordinator (Rick Stauffacher) · rstauffach@clinicaltrials.wisc.edu · 608-262-7722
    Contact: Principal Investigator (Steven Garlow)
Study leads
  • Charles Conway, MD

    Principal Investigator

    Washington University School of Medicine